Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer

Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer

Breast cancer remains one of the most common malignancies in female cancer patients. The rapid and accurate diagnosis of human epidermal growth factor receptor 2 (HER2) status is indispensable for breast cancer patients. The pre-miR-4728 (mir-4728) is encoded within an intron of the HER2 gene. We sh...

Full description

Bibliographic Details
Main Authors: Tao Rui, Aizhai Xiang, Jufeng Guo, Ning Tang, Xia Lin, Xin Jin, Jian Liu, Xiaobing Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Molecular Biosciences
Subjects:
breast cancer
HER2
mir-4728
early diagnosis
ESR
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.818493/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.818493/full

Similar Items